American Crystallographic Association (ACA) Summer School in Chemical Crystallography

In order to accelerate the development of life-saving drugs, it is essential to understand their solid-state properties. Being able to measure the crystallinity of a molecule and ultimately resolve the crystal structure is key to improving its stability and shelf life.

Improved Pharma is pleased to announce its sponsorship of the ACA 2022 Summer Course in Crystallography to be held this summer at Purdue University. The objective of the course is to provide appropriate training in theory as well as practical aspects of single crystal chemical crystallography and X-ray powder diffraction techniques for small molecules. Understanding crystallography and its role in the pharmaceutical field continues to grow in importance as more and more molecules are characterized for their solid-state properties.

“In order to accelerate the development of life-saving drugs, it is essential to understand their solid-state properties,” said Dr. Stephen Byrn, CSO of Improved Pharma. “Being able to measure the crystallinity of a molecule and ultimately resolve the crystal structure is key to improving its stability and shelf life. We are delighted to be able to support ACA Outreach in its efforts to educate young scientists so that they can discover these important techniques.”

Applications to take the course are open here.

About Pharmacy Improvement

Improved Pharma is a research and information company dedicated to improving pharmaceutical methods, formulations and processes. Services include solid state shape studies, formulation design, synchrotron techniques, analytical testing and expert advice for the development and defense of intellectual property matters. The company was founded in 2006 by Stephen and Sarah Byrn, who also founded SSCI.

For more information about Improved Pharma’s services, please contact us at 1-765-463-9951 or [email protected]

Share the article on social networks or by e-mail:

Comments are closed.